Kerentech is a consulting firm that helps biotech, medtech, and pharma companies with fundraising, licensing, partnerships, and business development. They specialize in facilitating investments between $2-30 million for early-stage companies. Kerentech has over 15 years of experience in technology transfer, fundraising, and business development. They provide these services to clients located around the world through their extensive network and deep market knowledge.

1. Kerentech: an
introduction
@ Kerentech Consulting S.L.

2. what we do
• Fundraising for medtech and biotech Companies
• Mediating between companies situated in different
continents, helping them to cooperate, despite
cultural gaps
• Helping biotech , medtech and pharma
companies to in-license
and/or out-license their
know-how, creating new
synergies
• Other businesses related
to finances and technology
transfer, like investor advising

3. • Our clients are sited in Israel, UK, USA, Spain,
Canada, China and India and other countries
• We have a global approach and give a global
service.
• Minimum transaction: €2M
Minimum development status:
– Biotech: Proof of Concept in animals, protected IP
– Medtech: Beta working prototype, protected IP
who are our clients

4. what are is our expertise and
what are our services
We have been in the market since 2004
• Facilitating investments until $ 30M for companies in development
• Helping investors to fundraise for their funds
• Worked in private investments in publicly traded companies.
• Done scouting for VCs, pharma and medtech companies
• Done Technology Transfer Negotiation
• Worked with incubators
• Found Strategic Partnerships
• Business Intelligence for client companies
(scouting)
• More than 150 clients have used our
services.

5. what is our strategy
-how we do it
• Deep knowledge of the markets where it
works.
• Extensive and strong network of personal
contacts
• Good knowledge of available investment
resources
• Deep technology knowledge
• Experience

6. Kerentech renders services to companies
looking for fundraising in the form of:
–Venture capital
–Business Angels
–Co-development agreements
–Joint ventures
–Participative loans
–Patent financing
fundraising

7. next events
Biotech Showcase 2018
January 7-9, 2018:: San Francisco, USA
BIO CEO & Investor 2018
February 12-13, 2018:: New York, USA
BioAsia 2018
February 22-24, 2018:: Hyderabad, India
BioWales 2018
March, 7, 2018:: Cardiff, United Kingdom

8. next events
BioEurope Spring 2017
March 20-22, 2017 :: Barcelona, Spain
BioAsia 2018
March 19-20, 2018:: Tokyo, Japan
MIXii Biomed 2018
May 15-17, 2018:: Tel Aviv, Israel
AngloNordic Life Science Conference
May 31, 2017:: London, United Kingdom

9. next events
BioEquity Europe 2017
May 14-16, 2018 :: Ghent, Belgium
BIO 2018
June 4-7, 2018 :: Boston, USA
Knowledge for growth 2018
May 17, 2018 :: Ghent, Belgium

10. contact
19 Ha Lamed Hey
93661 Jerusalem
Israel
info@kerentech.com
www.kerentech.com
@ Kerentech Consulting S.L.